Effect of Sitagliptin on Progression of Coronary Intermediate Lesion in Patients With Coronary Heart Disease Complicated With Type 2 Diabetes
Phase of Trial: Phase IV
Latest Information Update: 29 Jan 2018
At a glance
- Drugs Sitagliptin (Primary)
- Indications Atherosclerosis; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 24 Jan 2018 Status changed from recruiting to completed.
- 02 Feb 2017 Planned End Date changed from 1 Jan 2017 to 10 Mar 2017.
- 28 Jan 2016 New trial record